Ava Y Xu

MedicinePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis”.

Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis

Clinical Infectious Diseases(2024)10.1093/cid/ciae119

N/A

0.306DataRank · unranked

6 citations

Ava Y Xu, Gustavo E. Velásquez, Nan Zhang, Vincent Chang, Ekaterina V. Kurbatova +16 more

Calculating Pharmacokinetic Areas

Research Square(2022)10.21203/rs.3.rs-1934171/v1

N/A

0DataRank · unranked

0 citations

Anu Patel, Hirokazu Wakuda, Ava Y Xu, Leslie Z. Benet